Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: physical function

Biosimilar Drug Updates Reported from EULAR

Michele B. Kaufman, PharmD, BCGP  |  July 8, 2015

At the 2015 meeting of the European League Against Rheumatism in June, multiple studies were presented comparing the use of different biosimilar and biologic drugs in treating rheumatoid arthritis…

Filed under:Biologics/DMARDsDrug UpdatesEULAR/OtherMeeting Reports Tagged with:adalimumabBiologics & BiosimilarsetanerceptEULARRheumatiod arthritis

Knee Osteoarthritis Pain Worse with Insomnia

Lisa Rapaport  |  June 18, 2015

(Reuters Health)—People suffering from osteoarthritis, the most common type of joint inflammation, are more likely to have knee pain when they also have difficulty getting enough sleep, a study suggests. Researchers found that people with knee osteoarthritis and insomnia were also more likely to suffer from a nervous system disorder called “central sensitization” that makes…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis Care & Researchinsomniaknee osteoarthritisPainpatient care

Biosimilars for RA Studied in Multiple Trials

Michele B. Kaufman, PharmD, BCGP  |  June 17, 2015

Biosimilars for etanercept and sarilumab are being examined in multiple Phase 3 trials for their effects in RA and psoriasis patients.

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisRheumatoid Arthritis Tagged with:Biosimilarsclinical trialsPsoriatic Arthritis

Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Jennifer Stichman, MD, and Dennis J. Boyle, MD  |  April 1, 2015

Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:adherenceBoyleMedicationpatient carerheumatology

Value of Patient Care Services in Rheumatology Gets Boost

E. William St.Clair  |  April 1, 2015

By developing guidelines, quality measures, data on patient outcomes, the ACR helps rheumatologists translate the value of their work to the world

Filed under:Practice SupportPresident's Perspective Tagged with:AC&Rguidelineoutcomepatient carepratice managementQualityrheumatologistSt.Clair

Osteoimmunology Research May Benefit Patients with Rheumatoid Arthritis

Gretchen Henkel  |  January 1, 2015

Cross-talk between bone biology, immune system may shed light on joint erosion, refine therapeutic targets for RA

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch RheumRheumatoid Arthritis Tagged with:boneerosionHenkelImmunologyjointOsteoarthritisResearchRheumatoid arthritis

Patients with Rheumatoid Arthritis Should Exercise More, Sit Less

Lynne Feehan, PhD, PT, and Marie Westby, PhD, PT  |  November 1, 2014

Physical activity can improve mobility, strength and bone health, reduce fall risk for patients with RA

Filed under:ConditionsPatient PerspectivePractice SupportQuality Assurance/ImprovementRheumatoid Arthritis Tagged with:Exercisepatient carephysical activityRheumatoid arthritisrheumatologists

Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2014

Plus, rheumatology drug news, safety updates

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ataciceptBiologicsdrugKaufmanmavrilimumabResearchRheumatoid arthritisrheumatologistrheumatologyrituximabSafetySystemic lupus erythematosus

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP  |  August 1, 2014

Plus, rheumatology drug news from EULAR 2014

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)Ankylosing Spondylitisanti-inflammatorydrugEULARInternationalKaufmanMethotrexatePsoriatic ArthritisRheumatoid arthritisrheumatologistrheumatologySafetytocilizumabweight loss

EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

Thomas R. Collins  |  August 1, 2014

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:BiologicsCollinsEULARMethotrexateRheumatoid arthritisrheumatologistrheumatologyrituximabsarilumab

  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 81
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences